Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Rodeghier

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Blood Advances|February 23, 2022
Sustainability of low maternal mortality in pregnant women with SCD in a low-resource settingAlim Swarray-Deen, Eugenia V Asare, Ruth Ayettey Brew, et al.
Blood|October 14, 2010
Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell diseaseMonica L Hulbert, Robert C McKinstry, JoAnne L Lacey, et al.
British Journal of Haematology|September 11, 2012
Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemiaMathula Thangarajh, Genyan Yang, Dana Fuchs, et al.
Blood|March 12, 2025
A Controlled Trial for Preventing Priapism in Sickle Cell Anemia: Hydroxyurea plus Placebo vs Hydroxyurea plus TadalafilIbrahim Musa Idris, Aminu Abba Yusuf, Ismail Isah Ismail, et al.
American Journal of Hematology|June 9, 2020
Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trialNajibah A Galadanci, Shehu U Abdullahi, Shehi Ali Abubakar, et al.
Blood|March 17, 2024
An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell diseaseAdetola A Kassim, Josu de la Fuente, Erfan Nur, et al.
The Lancet. Haematology|December 31, 2021
Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trialShehu U Abdullahi, Binta W Jibir, Halima Bello-Manga, et al.
Pediatric Hematology and Oncology|November 25, 2020
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trialShehu U Abdullahi, Binta J Wudil, Halima Bello-Manga, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Blood Advances|February 23, 2022
Sustainability of low maternal mortality in pregnant women with SCD in a low-resource settingAlim Swarray-Deen, Eugenia V Asare, Ruth Ayettey Brew, et al.
Blood|October 14, 2010
Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell diseaseMonica L Hulbert, Robert C McKinstry, JoAnne L Lacey, et al.
British Journal of Haematology|September 11, 2012
Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemiaMathula Thangarajh, Genyan Yang, Dana Fuchs, et al.
Blood|March 12, 2025
A Controlled Trial for Preventing Priapism in Sickle Cell Anemia: Hydroxyurea plus Placebo vs Hydroxyurea plus TadalafilIbrahim Musa Idris, Aminu Abba Yusuf, Ismail Isah Ismail, et al.
American Journal of Hematology|June 9, 2020
Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trialNajibah A Galadanci, Shehu U Abdullahi, Shehi Ali Abubakar, et al.
Blood|March 17, 2024
An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell diseaseAdetola A Kassim, Josu de la Fuente, Erfan Nur, et al.
The Lancet. Haematology|December 31, 2021
Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trialShehu U Abdullahi, Binta W Jibir, Halima Bello-Manga, et al.
Pediatric Hematology and Oncology|November 25, 2020
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trialShehu U Abdullahi, Binta J Wudil, Halima Bello-Manga, et al.
Pageof 10